AI & ChatGPT searches , social queries for EVINACUMAB

Search references for EVINACUMAB. Phrases containing EVINACUMAB

See searches and references containing EVINACUMAB!

AI searches containing EVINACUMAB

EVINACUMAB

  • Evinacumab

    • Monoclonal antibody

    Evinacumab, sold under the brand name Evkeeza, is a monoclonal antibody medication for the treatment of homozygous familial hypercholesterolemia (HoFH)

    Evinacumab

    Evinacumab

  • Ultragenyx

    • American biopharmaceutical company

    trials. The company also holds the non-US commercial rights to Regeneron’s evinacumab-dgnb, which is approved by the FDA and EMA. The company also has therapies

    Ultragenyx

    Ultragenyx

    Ultragenyx

  • Monoclonal antibody

    • Antibodies from clones of the same blood cell

    Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab

    Monoclonal antibody

    Monoclonal antibody

    Monoclonal_antibody

  • Aducanumab

    • Monoclonal antibody against amyloid beta

    Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab

    Aducanumab

    Aducanumab

  • Alirocumab

    • Pharmaceutical drug

    Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab

    Alirocumab

    Alirocumab

  • Amitriptyline

    • Tricyclic antidepressant

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    Amitriptyline

    Amitriptyline

    Amitriptyline

  • Lecanemab

    • Monoclonal antibody against amyloid beta

    Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab

    Lecanemab

    Lecanemab

  • Erenumab

    • Chemical compound

    Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab

    Erenumab

    Erenumab

    Erenumab

  • Enoticumab

    • Monoclonal antibody

    Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab

    Enoticumab

    Enoticumab

  • Anti-amyloid antibodies

    • Drug class

    Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab

    Anti-amyloid antibodies

    Anti-amyloid_antibodies

  • Donanemab

    • Monoclonal antibody against amyloid beta

    Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab

    Donanemab

    Donanemab

  • Antineoplastic

    • Class of drugs used to treat malignant tumors

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    Antineoplastic

    Antineoplastic

    Antineoplastic

  • Evolocumab

    • Pharmaceutical drug

    Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab

    Evolocumab

    Evolocumab

  • Vanucizumab

    • Monoclonal antibody

    Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab

    Vanucizumab

    Vanucizumab

  • Bimagrumab

    • Chemical compound

    Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab

    Bimagrumab

    Bimagrumab

  • Testosterone

    • Primary male sex hormone

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    Testosterone

    Testosterone

    Testosterone

  • Prasinezumab

    • Experimental monoclonal antibody

    Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab

    Prasinezumab

    Prasinezumab

  • Ralpancizumab

    • Monoclonal antibody

    Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab

    Ralpancizumab

    Ralpancizumab

  • Romosozumab

    • Pharmaceutical drug

    Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab

    Romosozumab

    Romosozumab

  • Vascular endothelial growth factor

    • Protein involved in blood vessel growth

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    Vascular endothelial growth factor

    Vascular_endothelial_growth_factor

  • Erythropoietin

    • Protein that stimulates red blood cell production

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    Erythropoietin

    Erythropoietin

    Erythropoietin

  • Bedinvetmab

    • Monoclonal antibody

    Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab

    Bedinvetmab

    Bedinvetmab

    Bedinvetmab

  • KIT gene

    • Mammalian protein and protein-coding gene

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    KIT gene

    KIT gene

    KIT_gene

  • Fremanezumab

    • Pharmaceutical biological monoclonal antibody

    Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab

    Fremanezumab

    Fremanezumab

  • Fibroblast growth factor receptor-like 1

    • Protein found in humans

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    Fibroblast growth factor receptor-like 1

    Fibroblast growth factor receptor-like 1

    Fibroblast_growth_factor_receptor-like_1

  • Humanized antibody

    • Antibodies from non-human species made nearly identical to human ones

    Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab

    Humanized antibody

    Humanized_antibody

  • Brigatinib

    • ALK inhibitor for treatment of non-small-cell lung cancer

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    Brigatinib

    Brigatinib

    Brigatinib

  • Emicizumab

    • Monoclonal antibody

    Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab

    Emicizumab

    Emicizumab

    Emicizumab

  • Concizumab

    • Medication

    Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab

    Concizumab

    Concizumab

  • Robert Hegele

    • drugs, including rosuvastatin, sitagliptin, evolocumab, inclisiran, and evinacumab. Several of these treatments became standard therapies following successful

    Robert Hegele

    Robert_Hegele

  • Platelet-derived growth factor receptor

    • Cell surface receptors

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    Platelet-derived growth factor receptor

    Platelet-derived growth factor receptor

    Platelet-derived_growth_factor_receptor

  • Marstacimab

    • Medication

    Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab

    Marstacimab

    Marstacimab

  • Dihexa

    • Chemical compound

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    Dihexa

    Dihexa

    Dihexa

  • Anti-α-synuclein drug

    • Drugs that inhibit α-synuclein

    Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab

    Anti-α-synuclein drug

    Anti-α-synuclein_drug

  • Dexamethasone

    • Corticosteroid medication

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    Dexamethasone

    Dexamethasone

    Dexamethasone

  • Repotrectinib

    • Medication

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    Repotrectinib

    Repotrectinib

    Repotrectinib

  • Transforming growth factor

    • Biomarker indicative of breast cancer patients' prognosis

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    Transforming growth factor

    Transforming_growth_factor

  • Galcanezumab

    • Monoclonal antibody

    Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab

    Galcanezumab

    Galcanezumab

    Galcanezumab

  • Insulin-like growth factor 1

    • Protein found in humans

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    Insulin-like growth factor 1

    Insulin-like growth factor 1

    Insulin-like_growth_factor_1

  • Familial hypercholesterolemia

    • Genetic disorder characterized by high cholesterol levels

    hypercholesterolemia. Gene therapy is a possible future alternative. Evinacumab, a monoclonal antibody inhibiting angiopoietin-like protein 3, was approved

    Familial hypercholesterolemia

    Familial hypercholesterolemia

    Familial_hypercholesterolemia

  • Figitumumab

    • Chemical compound

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    Figitumumab

    Figitumumab

  • ACD856

    • TrkA and TrkB positive modulator

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    ACD856

    ACD856

  • Binimetinib

    • Chemical compound

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    Binimetinib

    Binimetinib

    Binimetinib

  • Neurotrophin

    • Family of proteins

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    Neurotrophin

    Neurotrophin

    Neurotrophin

  • Relfovetmab

    • Veterinary medication

    Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab

    Relfovetmab

    Relfovetmab

  • Denosumab

    • Human monoclonal antibody

    Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab

    Denosumab

    Denosumab

  • R13 (drug)

    • Chemical compound

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    R13 (drug)

    R13 (drug)

    R13_(drug)

  • Brain-derived neurotrophic factor

    • Protein found in humans

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    Brain-derived neurotrophic factor

    Brain-derived neurotrophic factor

    Brain-derived_neurotrophic_factor

  • Heparin-binding EGF-like growth factor

    • Protein-coding gene in the species Homo sapiens

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    Heparin-binding EGF-like growth factor

    Heparin-binding EGF-like growth factor

    Heparin-binding_EGF-like_growth_factor

  • Fibroblast growth factor

    • Family of proteins involved in anatomical development

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    Fibroblast growth factor

    Fibroblast_growth_factor

  • Idarucizumab

    • Medication

    Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab

    Idarucizumab

    Idarucizumab

  • Trevogrumab

    • Monoclonal antibody

    Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab

    Trevogrumab

    Trevogrumab

  • Caplacizumab

    • Chemical compound

    Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab

    Caplacizumab

    Caplacizumab

  • Fibroblast growth factor 21

    • Protein-coding gene in mammals

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    Fibroblast growth factor 21

    Fibroblast growth factor 21

    Fibroblast_growth_factor_21

  • Growth factor

    • Protein or other substance that stimulates cellular proliferation

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    Growth factor

    Growth_factor

  • Bevacizumab

    • Medication

    Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab

    Bevacizumab

    Bevacizumab

  • Dehydroepiandrosterone

    • Chemical compound

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    Dehydroepiandrosterone

    Dehydroepiandrosterone

    Dehydroepiandrosterone

  • Vascular endothelial growth factor B

    • Protein-coding gene in the species Homo sapiens

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    Vascular endothelial growth factor B

    Vascular endothelial growth factor B

    Vascular_endothelial_growth_factor_B

  • MST1

    • Protein-coding gene in the species Homo sapiens

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    MST1

    MST1

    MST1

  • Testosterone (medication)

    • Medication and naturally occurring steroid hormone

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    Testosterone (medication)

    Testosterone (medication)

    Testosterone_(medication)

  • Insulin

    • Peptide hormone

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    Insulin

    Insulin

    Insulin

  • EPHA7

    • Protein-coding gene in humans

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    EPHA7

    EPHA7

    EPHA7

  • Rociletinib

    • Cancelled developmental cancer drug

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    Rociletinib

    Rociletinib

    Rociletinib

  • Burosumab

    • Monoclonal antibody designed to treat X-linked hypophosphatemia

    Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab

    Burosumab

    Burosumab

  • Izenivetmab

    • Veterinary medication

    Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab

    Izenivetmab

    Izenivetmab

  • Imatinib

    • Chemical compound

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    Imatinib

    Imatinib

    Imatinib

  • List of therapeutic monoclonal antibodies

    • TIGIT Etrolizumab mab humanized integrin β7 inflammatory bowel disease Evinacumab Evkeeza mab human angiopoietin 3 Y dyslipidemia Evolocumab Repatha mab

    List of therapeutic monoclonal antibodies

    List of therapeutic monoclonal antibodies

    List_of_therapeutic_monoclonal_antibodies

  • Anti-VEGF

    • Medication which blocks growth of blood vessels

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    Anti-VEGF

    Anti-VEGF

    Anti-VEGF

  • Tropoflavin

    • Chemical compound

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    Tropoflavin

    Tropoflavin

    Tropoflavin

  • ATC code C10

    • Pharmaceutical drug classification

    C10AX14 Alirocumab C10AX15 Bempedoic acid C10AX16 Inclisiran C10AX17 Evinacumab C10AX18 Volanesorsen C10AX19 Lerodalcibep C10BA01 Lovastatin and nicotinic

    ATC code C10

    ATC_code_C10

  • Crenezumab

    • Antibody tested against Alzheimer's

    Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab

    Crenezumab

    Crenezumab

  • Gantenerumab

    • Monoclonal antibody protein

    Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab

    Gantenerumab

    Gantenerumab

    Gantenerumab

  • Eptinezumab

    • Monoclonal antibody

    Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab

    Eptinezumab

    Eptinezumab

  • Blosozumab

    • Chemical compound

    Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab

    Blosozumab

    Blosozumab

  • Prasterone enanthate

    • Chemical compound

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    Prasterone enanthate

    Prasterone enanthate

    Prasterone_enanthate

  • GFRA1

    • Protein-coding gene in the species Homo sapiens

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    GFRA1

    GFRA1

    GFRA1

  • Wnt signaling pathway

    • Group of signal transduction pathways involved in embryonic development

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    Wnt signaling pathway

    Wnt_signaling_pathway

  • Solanezumab

    • Monoclonal antibody medication

    Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab

    Solanezumab

    Solanezumab

  • Receptor tyrosine kinase

    • Class of enzymes

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    Receptor tyrosine kinase

    Receptor tyrosine kinase

    Receptor_tyrosine_kinase

  • Fibroblast growth factor receptor 3

    • Gene involved in the most common form of dwarfism

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    Fibroblast growth factor receptor 3

    Fibroblast growth factor receptor 3

    Fibroblast_growth_factor_receptor_3

  • Bapineuzumab

    • Chemical compound

    Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab

    Bapineuzumab

    Bapineuzumab

  • IGF-1 LR3

    • Synthetic protein

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    IGF-1 LR3

    IGF-1_LR3

  • HER2

    • Mammalian protein found in humans

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    HER2

    HER2

    HER2

  • Abciximab

    • Pharmaceutical compound

    Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab Evinacumab Evolocumab Icrucumab Inclacumab Marstacimab Nesvacumab Orticumab Ramucirumab

    Abciximab

    Abciximab

    Abciximab

  • Epidermal growth factor receptor

    • Transmembrane protein

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    Epidermal growth factor receptor

    Epidermal growth factor receptor

    Epidermal_growth_factor_receptor

  • Trastuzumab

    • Medication

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    Trastuzumab

    Trastuzumab

    Trastuzumab

  • Amitriptyline/perphenazine

    • Combination drug

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    Amitriptyline/perphenazine

    Amitriptyline/perphenazine

    Amitriptyline/perphenazine

  • E2511

    • Pharmaceutical compound

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    E2511

    E2511

  • Nerve growth factor

    • Mammalian protein found in humans

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    Nerve growth factor

    Nerve growth factor

    Nerve_growth_factor

  • Filgrastim

    • Medication

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    Filgrastim

    Filgrastim

    Filgrastim

  • Tesevatinib

    • Chemical compound

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    Tesevatinib

    Tesevatinib

    Tesevatinib

  • Dehydroepiandrosterone sulfate

    • Chemical compound

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    Dehydroepiandrosterone sulfate

    Dehydroepiandrosterone sulfate

    Dehydroepiandrosterone_sulfate

  • Tyrosine kinase inhibitor

    • Drug typically used in cancer treatment

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    Tyrosine kinase inhibitor

    Tyrosine kinase inhibitor

    Tyrosine_kinase_inhibitor

  • Norwogonin

    • Chemical compound

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    Norwogonin

    Norwogonin

    Norwogonin

  • Lenvatinib

    • Chemical compound

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    Lenvatinib

    Lenvatinib

    Lenvatinib

  • Cetuximab

    • Pharmaceutical drug

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    Cetuximab

    Cetuximab

    Cetuximab

  • Prasterone

    • Medical usage of the prasterone compound

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    Prasterone

    Prasterone

    Prasterone

  • List of drugs granted breakthrough therapy designation

    • adults, as monotherapy or in conjunction with an oral antidepressant Evinacumab As an adjunct to diet and exercise and other low-density lipoprotein-cholesterol

    List of drugs granted breakthrough therapy designation

    List_of_drugs_granted_breakthrough_therapy_designation

  • Erlotinib

    • Medication for treatment of non-small-cell lung cancer

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    Erlotinib

    Erlotinib

    Erlotinib

  • Pertuzumab/trastuzumab/hyaluronidase

    • Combination drug

    Angiopoietin 3 Kinase inhibitors: Altiratinib CE-245677 Rebastinib Antibodies: Evinacumab (against angiopoietin 3) Nesvacumab (against angiopoietin 2) CNTF Agonists:

    Pertuzumab/trastuzumab/hyaluronidase

    Pertuzumab/trastuzumab/hyaluronidase

AI & ChatGPT searchs for online references containing EVINACUMAB

EVINACUMAB

AI search references containing EVINACUMAB

EVINACUMAB

AI search queries for Facebook and twitter posts, hashtags with EVINACUMAB

EVINACUMAB

Follow users with usernames @EVINACUMAB or posting hashtags containing #EVINACUMAB

EVINACUMAB

Online names & meanings

AI search & ChatGPT queries for Facebook and twitter users, user names, hashtags with EVINACUMAB

EVINACUMAB

Top AI & ChatGPT search, Social media, medium, facebook & news articles containing EVINACUMAB

EVINACUMAB

AI searchs for Acronyms & meanings containing EVINACUMAB

EVINACUMAB

AI searches, Indeed job searches and job offers containing EVINACUMAB

Other words and meanings similar to

EVINACUMAB

AI search in online dictionary sources & meanings containing EVINACUMAB

EVINACUMAB